Nos publications > > Articles > 2019

Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitis

Lien vers la publication

Montante A, Le Bras A, Pagnoux C, Perrodeau E, Ravaud P, Terrier B, Guillevin L, Durand-Zaleski I ; French Vasculitis Study Group.
Clin Exp Rheumatol. 2019 Mar-Apr

Dernière mise à jour le 6/06/2019